To understand whether the mutated SF3B1 expression has an apparent impact on response to the MDM2 inhibitors, the LC50 values of RG7388 for the p53 functional (TP53WT) CLL samples were plotted against the SF3B1 status. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.